0.54 0.04 (8.00%)

New 52W Low in past week

6.9M XNAS Volume

XNAS 01 Apr, 2025 5:30 PM (EDT)



Insider Trading disclosures for TransCode Therapeutics Inc

The latest disclosure was made by Erik Manting in TransCode Therapeutics Inc where a trade of 70,000 Stock Option (right to buy) done was reported to US exchanges on June 14, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Erik Manting Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 70,000 70,000 - - Stock Option (right to buy)
Thomas A. Fitzgerald Director, Interim CEO, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 650,000 650,000 - - Stock Option (right to buy)
Magda Marquet Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 70,000 70,000 - - Stock Option (right to buy)
Philippe P. Calais Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 70,000 70,000 - - Stock Option (right to buy)
Robert Michael Dudley Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.65 per share. 20 Jun 2023 12,000 82,262 - 2.7 31,818 Common Stock
Robert Michael Dudley Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.55 per share. 20 Jun 2023 6,607 70,262 - 2.5 16,847 Common Stock
Robert Michael Dudley Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.76 per share. 09 Jun 2023 19,000 912,114 - 2.8 52,440 Common Stock
Philippe P. Calais Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 9,500 9,500 - - Stock Option (Right to Buy)
Magda Marquet Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 9,500 9,500 - - Stock Option (Right to Buy)
Erik Manting Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 9,500 9,500 - - Stock Option (Right to Buy)
Robert Michael Dudley Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2022 135,000 135,000 - - Stock Option (Right to Buy)
Zdravka Medarova Chief Technology Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2022 60,000 60,000 - - Stock Option (Right to Buy)
Thomas A. Fitzgerald Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2022 100,000 100,000 - - Stock Option (Right to Buy)
Robert Michael Dudley Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.15 per share. 14 Sep 2022 20,000 893,114 - 1.2 23,000 Common Stock
Philippe P. Calais Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 9,500 9,500 - - Stock Option (Right to Buy)
Erik Manting Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 9,500 9,500 - - Stock Option (Right to Buy)
Magda Marquet Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 9,500 9,500 - - Stock Option (Right to Buy)
Thomas A. Fitzgerald Director, Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.27 per share. 16 Jun 2022 12,000 139,377 - 1.3 15,240 Common Stock
Robert Michael Dudley Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.87 per share. 27 May 2022 2,000 873,114 - 1.9 3,740 Common Stock
Robert Michael Dudley Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.84 per share. 27 May 2022 28,000 871,114 - 1.8 51,643 Common Stock
Thomas A. Fitzgerald Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 52,000 52,000 - - Stock Option (Right to Buy)
Zdravka Medarova Chief Technology Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 33,000 33,000 - - Stock Option (Right to Buy)
Thomas A. Fitzgerald Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 33,000 33,000 - - Stock Option (Right to Buy)
Robert Michael Dudley Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 135,000 135,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures